What is FIND ?

FIND

mission

Promote the development and early implementation of innovative diagnostic tests that contribute significantly to patient care and disease management in resource-poor environments.
 

FIND Initiatives

1. By developing diagnostic tests, we will realize a medical and health system that can provide appropriate treatment to patients and invest resources where they are needed.
2 .Accelerate the deployment of diagnostics through project management: ISO13485 certification for project management and clinical trials
3. Earn preferential prices for investment
4. Strengthen local lab facilities and make new technologies available to everyone.
 

Achievements of FIND

1.tuberculosis

Introducing 6 new technologies
・40% improvement in case detection rate, shortened time to treatment decision for multidrug-resistant tuberculosis from months to hours
・Save up to 300,000 people a year
Adopted in 25 highly epidemic countries due to national policy changes
・Detected 25,000 cases of multidrug-resistant tuberculosis in 2012 alone: Education and training for more than 2,000 staff at more than 80 new laboratories
 

2.Malaria & Acute Febrile Syndrome

Quality evaluation of rapid diagnostic test by FIND / WHO
・Fourx more than rapid diagnostic tests: Low quality product percentage dropped from 76% to 17%
・Efforts to respond to 85% of misdiagnosis and treatment, and to reduce drug-resistant cases
LAMP method: potential as a tool for disease elimination, currently used for mass screening in the first three countries
Blood Transfer Device: Estimated 50 million units sold in 2012
 

3.African Trypanosomasis & Neglected Diseases

Introducing two new technologies for the first-ever rapid diagnostic test for the definitive diagnosis of African trypanosomiasis
Successful support programs in 11 endemic countries in Africa
FIND technology will be adopted in a country-led African Trypanosomiasis Elimination Campaign.
 

 


  

 
 

Consultant
Research & Innovation Japan Inc.

Consultation in biotech and in vitro diagnostic business
 

What is the outline of RIJ’s consultant business?

RIJ is a consulting company for biotechnology and in vitro diagnostics. RIJ prepares the launch pad for foreign companies to introduce their products in the Japanese market. The main activity of RIJ is to offer consulting services to foreign companies
who want to bring their products with a unique technology to Japan. RIJ advises the companies on the modalities of the Japanese market and assist in the promotion, marketing and distribution of the foreign company’s products in Japan.

 

How does RIJ make leverage on this consulting business?

The market in Japan comprises of small-, medium-and large-scale manufacturers of diagnostics and biotechnology products. Japan is also filled
with wholesalers who distribute the products to the end-users. RIJ’s role is to act as a bridge between the manufacturer and wholesaler. In addition, RIJ advises local manufacturers who wish to expand their technology to overseas market. It is RIJ’s responsibility to identify the right distributor both within and outside the boundaries of Japan (please see attached article).
Mr. K.Hirasawa, CEO of RIJ was in Boehringer Mannheim kk and Roche Diagnostic Inc for 25 years totally. And he is now a Business Adviser of Foundation Innovative New Diagnostics(FIND) in Japan.

Please contact us. RIJ will help your firm to find appropriate marketing partner to make your business successfully in Japan. 
 
downlord (200KB)


 

 
 
 

Products handled by
Research & Innovation Japan Inc.

 
 

GENERI BIOTECH

[RUO] gb GENETIC APOE
Detection method: allelic discrimination
This kit is intended for detection of mutations rs429358 and rs7412 in the gene for APOE in human genomic DNA. It enables determination of e2 (cys112, cys158), e3 (cys112, arg158) and e4 (arg112, arg158) genotypes. Examination process is based on a principle of real-time PCR with the use of fluorescently labelled probes (allelic discrimination).


iNtRON Biotechnology

[RUO] LiliF™ ABPV/KBV/IAPV/CBPV Real-time RT-PCR Kit is able to detect directly and specifically honey bee RNA viruses such as ABPV, KBV, IAPV and CBPV by real-time PCR technology on the basis of a genetic database of target nucleic acid fragments. Therefore, this kit can diagnose very sensitive, fast and accurately.
[RUO] LiliF™ SBV/KSBV/DWV/BQCV Real-time RT-PCR Kit is able to detect directly and specifically honey bee RNA viruses such as SBV, KSBV, DWV and BQCV by real-time PCR technology on the basis of a genetic database of target nucleic acid fragments.


AB Analitica

Kit for detection of 20 high-risk and 2 low-risk genotypes of the Human Papillomavirus by Real-Time PCR (regions E6-E7) [RUO] 
 
Allows through two PCRs on the HPV gene regions E6 and E7 detection of the 14 most common high-risk HPV types (HPV 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68) and the 8 most common possibly high-risk (HPV 26, 53, 67, 70, 73, 82) and 2 low-risk HPV types (HPV 6, 11) as well as direct genotyping of HPV 16, 18, 6 and 11.
 
The kit includes:
・Ready-to-use reagents for Real-Time PCR
・PCR control (PCR on beta-globin gene [BG])
・Positive controls (DNA containing fragments of the genomes of HPV 16, 18 and 33 and the BG gene and DNA containing fragments of the genomes of HPV 6, 11 and 26 and the BG gene)
 


FORA

For blood glucose measurement in experimental animals
Introducing Lab Gluco [RUO] , a quick and easy measuring device
・Palm-sized simple measuring device
・Measurement time is only 5 seconds
・Required sample volume is only 1.1 μL
・Sensor that is easy to handle
・Hygienic disposal with injector
・Accurate measurement with a wide range of hematocrit tolerance
 


LogTag

TRIX-8
MULTI-USE TEMPERATURE LOGGER

・WHO PQS Pre-qualified under E06/06: PQS CODE E006/00.
・Versatile, wide range, multi-trip Temperature Logger.
・8000 readings memory capacity with up to 3 years battery life.
・‘OK’ & ‘ALERT’ Indicator with high and low customizable alarms.
・Industry best download time – less than 5 seconds for full memory.
 
The LogTag® TRIX-8 is a versatile, wide range, multi-trip Temperature Logger, featuring high-resolution temperature readings over a measurement range of -40°C to +85°C (-40°F to +185°F). Enclosed in a robust and durable polycarbonate case, the TRIX-8 features a real-time clock, which provides date/time stamps for each temperature reading.
 
Using the LogTag® Interface and the freely available companion software LogTag Analyzer, the LogTag® is easily set-up for recording conditions including delayed start, sampling interval, number of readings, continuous or fixed number of readings and configuration of conditions to activate the ALERT indicator.
Readings are downloaded using LogTag® Analyzer, which provides facilities for charting, zooming, listing data statistics and allows exporting the data to other applications such as Excel.
 
The LogTag® TRIX-8 complies with the relevant international standards for temperature monitoring devices, such as FCC, CE, C-TICK, TÜV, EN12830, WHO PQS and RoHS.
This not only demonstrates the quality of the LogTag® TRIX-8, but underlines its suitability for temperature monitoring applications where accuracy and consistency are required.
 


Microsynth : The Swiss DNA Company

Microsynth (founded in 1989) is a leading European company in the area of nucleic acid synthesis & analysis. The main activities are divided into following three business areas:
 
1.DNA/RNA Synthesis
2.DNA/RNA Analysis and Sequencing
3.Contract Research/Outsourcing

For almost three decades, the companys' objective has been to serve its customers by delivering products and services of the highest quality, on time and with outstanding service – and all this at competitive prices.
 
URL: Microsynth Site